Preclinical characterization of novel TS inhibitor DG-1 presented
Aug. 23, 2023
Thymidylate synthase (TS) is an enzyme essential for DNA synthesis and cell proliferation and is a potential oncoprotein itself. Consequently, TS is considered a molecular target for malignant tumors.